Rua Bioscience Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was NZD 0.357675 million compared to NZD 0.024226 million a year ago. Revenue was NZD 6.53 million compared to NZD 0.646098 million a year ago.

Net loss was NZD 5.96 million compared to NZD 8.64 million a year ago. Basic loss per share from continuing operations was NZD 0.04 compared to NZD 0.06 a year ago. Diluted loss per share from continuing operations was NZD 0.04 compared to NZD 0.06 a year ago.